Powder: -20°C for 3 years | In solvent: -80°C for 1 year
QNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 47.00 | |
10 mg | In stock | $ 84.00 | |
25 mg | In stock | $ 169.00 | |
50 mg | In stock | $ 319.00 | |
100 mg | In stock | $ 531.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 52.00 |
Description | QNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist. |
Kinase Assay | Biochemical filter-binding assays for detection of FGFR phosphorylation activities : Reaction mixtures contains 8 mM Tris-HCl (pH 7.5), 10 mmol/L HEPES, 5 mM dithiothreitol, 10 μM ATP, 0.5 μCi 33P-ATP, 10 mM MnCl2, 150 mM NaCl, 0.01% Triton X-100, 4% dimethyl sulfoxide, 0.05 mg/mL poly(Glu:Tyr) (4:1, average molecular weight of 20–50 kDa), and 7.5, 7.5, and 16 ng of FGFR1, FGFR3, and FGFR4, respectively, and are incubated at room temperature for 30 minutes followed by termination with 10% H3PO4. The reaction mixtures are transferred to 96-well MAFB filter plates that are washed 3 times with 0.5% H3PO4. After air-drying, the plates are read with a Trilux reader. |
Molecular Weight | 443.41 |
Formula | C24H17N3O6 |
CAS No. | 1237744-13-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.43 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
QNZ46 1237744-13-6 Membrane transporter/Ion channel Neuroscience iGluR NMDAR QNZ-46 Ionotropic glutamate receptors inhibit Inhibitor QNZ 46 inhibitor